Novartis Pharma
Asia, Tokyo, Japan, Tokyo
Description
Novartis Pharma is the Japanese subsidiary of Novartis Pharmaceuticals, a world-leading healthcare company based in Basel, Switzerland
Investor Profile
Novartis Pharma has backed more than 7 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 3 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series C, Series B, Post Ipo Equity rounds (top funding stages).
- Majority of deals are located in United States, Germany.
- Strong thematic focus on Biotechnology, Health Care, Therapeutics.
Stage Focus
- Series C (43%)
- Series B (29%)
- Post Ipo Equity (14%)
- Series A (14%)
Country Focus
- United States (86%)
- Germany (14%)
Industry Focus
- Biotechnology
- Health Care
- Therapeutics
- Medical Device
- Cloud Computing
- Enterprise Software
- Software
- Health Diagnostics
- Artificial Intelligence (Ai)
- Biopharma
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
Who does Novartis Pharma frequently co-invest with?
Which angels does Novartis Pharma often collaborate with?
What are some of recent deals done by Novartis Pharma?
Find More Investors Like Novartis Pharma
Discover similar investors in our database and build your perfect investor list.
Need help with your fundraising strategy?Read our fundraising guides
